bullish

VA Tech Wabag

Healthy execution, but cashflow concerns persist

166 Views23 Nov 2021 17:02
Broker
VA Tech Wabag’s Q2FY22 healthy performance was supported by pick-up in execution leading to healthy operating margins. Revenues grew 12.4% YoY to Rs 6.8bn.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 1-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
ICICI Securities Limited
External broker reports(aggregated public sources)
ICICI Securities Ltd
IndiaEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Healthy execution, but cashflow concerns persist
    23 Nov 2021
x